Enter your keywords
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
Papers of the Week
The HBO Alzheimer's Project
My AlzForum Home
AlzRisk Paper Detail
Non-Steroidal Anti-Inflammatory Drugs
Uppsala Longitudinal Study of Adult Men
Average Follow-up Time Detail
Follow-up was defined as the time from the baseline examination to the date of diagnosis of AD, the date of diagnosis of any other cognitive impairment making the subsequent diagnosis of AD impossible, the date of death, the date of move away from Uppsala county (n=16), or the end of the follow-up period on December 31, 2005.
In this study, the investigators were working with two cohorts defined by age at baseline, each of which contributes a row to this table. This entry reflects consideration of the 1062 participants who were approximately 70 years old at baseline.
The median follow-up from the age 70 examination was 11.3 years (range 1.01-14.3 years).
"High sensitivity IL-6 was analyzed by an ELISA kit (IL-6 HS, R&D Systems, Minneapolis, MN). Samples and standards were pipetted in a microtiter plate coated with monoclonal antibody against IL-6. After incubation, a washing enzyme substrate solution was pipetted and followed by anti-IL-6 antibody. The color reaction was proportional to the bound IL-6. The total CV of the method was 7% and the interassay CV was 5%."
In their original report, the authors reported serum IL-6 levels in units of mg/L. However, this was a typographical error, and the units were, in fact, pg/mL (J. Sundelöf, personal communication, March 30, 2010).
All participants were residents of Uppsala, Sweden.
The authors stratified results by age at baseline. This entry summarizes the results for those who were age 70 at baseline.
Screening and Diagnosis Detail
Mini-Mental State Examination (Folstein 1975)
Diagnostic and Statistical Manual IV
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Sundelof et al. 2008
) "Subjects with low test performance (Mini-Mental State Examination [MMSE] score
26; or at age 82 years, MMSE score <+u>< 26 and/or 7-minute screen = high risk), were referred to the Geriatric Memory Clinic at the Uppsala University Hospital for a thorough clinical assessment. Further, all available medical records from the Uppsala University Hospital, all general practitioners in Uppsala (private and/or public), and all community nursing homes and dementia group living settings were reviewed on all subjects (n = 1,153) from 1990 up to December 31, 2005, regardless of the results on the cognitive screening."
Total dementia definition:
All-cause dementia cases included cases with:
(1) AD (defined with NINCDS-ADRDA and DSM-IV criteria), (2) AD and cerebral vascular disease (AD+CVD) (defined as AD cases with <= 2 clinically silent brain infarctions, (3) vascular dementia (VaD) (defined with Chui criteria), and (4) dementia not otherwise specified (NOS).
Covariates & Analysis Detail
Cox proportional hazards regression
Levels of IL-6 were evaluated as both continuous and categorical variables (above or below/at the median). This table reports the results for IL-6 treated as a continuous variable.
APOE e4 genotype
body mass index
APOE e4 genotype
body mass index